Skip to content

Comparison of therapeutic effects of linseedd oil topical gel, with wrist splint in carpal tunnel syndrome

Comparing the effect of a topical traditional medicine product based on linseed oil, with standard therapy of medical wrist splint in reducing sensory and functional symptoms of mild to moderate idiopathic carpal tunnel syndrome. – A randomized clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014112120023N1
Enrollment
80
Registered
2015-05-12
Start date
2015-05-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carpal tunnel syndrome. carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: linseed oil-based topical gel, twice daily, morning and night for three weeks, each time at least in amount of distal phalanx of index finger is gently rubbed on
Treatment - Drugs
standard group: standard CTS splint, only at night for three weeks.
Intervention group: linseed oil-based topical gel, twice daily, morning and night for three weeks, each time at least in amount of distal phalanx of index finger is gently rubbed on the palmar surf

Sponsors

Tehran University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients of both sexes in the age range of 20 to 60 years; clinically diagnosed CTS by a specialist; confirmed mild to moderate CTS by electrodiagnosis report; signing the informed consent form and accept the terms of participation in the study. Exclusion criteria: the inability to filling forms (mental disability or speech impairment); history of trauma or surgery in carpal tunnel region or direct injection into the tunnel of carp; pregnancy; history of diabetes and thyroid disorders announced by the patient; median nerve involvement in areas other than the carpal region that is established with the clinical diagnosis and NCV; history of collagen vascular diseases such as rheumatoid arthritis, scleroderma, amyloidosis, lupus and synchronization with other tenosynovitis certified by rheumatologist; history of dermal reaction due to the use of local products; history of allergy to topical or oral compositions of linen; recent cancer chemotherapy and radiotherapy; taking corticosteroids, immunosuppressants and cytotoxic agents; serious medical conditions such as kidney or heart failure or cancer; pathological obesity or leanness (based on BMI); thenar muscle atrophy; permanent paresthesia; severe type of CTS in NCV.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Sensory symptoms in CTS. Timepoint: 3 week. Method of measurement: standard Boston questionnaire.;Functional status of hand. Timepoint: 3 week. Method of measurement: standard Boston questionnaire.

Secondary

MeasureTime frame
Local side effect of topical gel. Timepoint: first day, end of third week. Method of measurement: history and clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Setayesh

Tehran University of Medical Science

m-setayesh@razi.tums.ac.ir msetayeshmail@gmail.com+98 21 2298 8551

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026